Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: Cancer Res. 2010 Mar 30;70(8):3278–3286. doi: 10.1158/0008-5472.CAN-09-3024

Table 2.

Pre-treatment hormone levels (pg/ml) and during anastrozole therapy

Pre-treatment (n=191) During Anastrozole (n=191)
Estrone
    No. patients 189 191
    Missing 2 0
    Mean (SD) 23.2 (15.64) 1.0 (4.28)
    Median 19.9 0.0
    Range 0.0-111.0 0.0-45.2
Estradiol
    N. patients 188 189
    Missing 3 2
    Mean (SD) 5.8 (5.41) 1.1 (7.75)
    Median 3.9 0.0
    Range 0.0-40.3 0.0-97.0
Estrone conjugates
    No. patients 189 190
    Missing 2 1
    Mean (SD) 340.5 (386.78) 53.4 (239.15)
    Median 226.0 12.1
    Range 7.7-3320.0 0.0-2990.0
Androstenedione
    No. patients 189 191
    Missing 2 0
    Mean (SD) 515.8 (310.85) 573.3 (303.73)
    Median 451.0 486.0
    Range 0.0-2470.0 0.0-1560.0
Testosterone
    No. patients 187 191
    Missing 4 0
    Mean (SD) 183.4 (134.53) 183.1 (116.92)
    Median 151.0 160.0
    Range 0.0-1120.0 0.0-678.0